Fig. 1.
Prescription rate of cardiovascular risk-lowering medications and antidiabetic medications at discharge after event in type 2 diabetes mellitus with established cardiovascular disease. The inset graph shows the number of class of antidiabetic medications. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blockade; DPP4i, dipeptidyl peptidase 4 inhibitor; SGLT2i, sodium-glucose cotransporter 2 inhibitor; TZD, thiazolidinedione; AGI, alpha-glucosidase inhibitor; GLP-1RA, glucagon-like peptide 1 receptor agonist.